{"id":852664,"date":"2025-05-20T07:08:32","date_gmt":"2025-05-20T11:08:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/"},"modified":"2025-05-20T07:08:32","modified_gmt":"2025-05-20T11:08:32","slug":"more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/","title":{"rendered":"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies<\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">PLEASANTON, Calif.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">May 20, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/www.veeva.com\/\" target=\"_blank\" rel=\"nofollow\">Veeva Systems<\/a> (NYSE: VEEV) today announced that <a href=\"https:\/\/vaultbasics.veeva.com\/\" target=\"_blank\" rel=\"nofollow\">Veeva Basics<\/a> is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and gaining a system that can scale as they expand their business. The rapid adoption of Veeva Basics signals a shift from disparate entry-level tools toward complete, best-of-breed solutions that can support biotechs today and as they grow.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.jpg\" title=\"Veeva Systems (PRNewsfoto\/Veeva Systems)\" alt=\"Veeva Systems (PRNewsfoto\/Veeva Systems)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Designed specifically for fast-growing companies, Veeva Basics provides pre-configured and pre-validated solutions. This enables fast deployment and adoption regardless of company size. With clinical, regulatory, and quality solutions available, Veeva is adding two new applications for biotechs:<\/p>\n<ul type=\"disc\">\n<li>\n          <b>Veeva CTMS Basics<\/b> for clinical trial management, including milestones, monitoring, enrollment, issue resolution, and site communications.<\/li>\n<li>\n          <b>Veeva Submissions Publishing Basics<\/b>\u00a0for building, publishing, and transmitting regulatory submissions in a single system.<\/li>\n<\/ul>\n<p>&#8220;More biotechs are adopting Veeva Basics in <span class=\"xn-location\">North America<\/span> and <span class=\"xn-location\">Europe<\/span>, driving savings in time, cost, and effort,&#8221; said <span class=\"xn-person\">Steve Harper<\/span>, general manager of Veeva Basics. &#8220;Our approach to deliver pre-configured and pre-validated solutions that can go live quickly is gaining momentum, and we&#8217;re adding new clinical and regulatory solutions to meet the needs of high-growth companies. With complete cloud applications, biotechs can ensure they are always current and benefit from the latest features.&#8221;<\/p>\n<p>Veeva CTMS Basics and Submissions Publishing Basics are available today in <span class=\"xn-location\">North America<\/span> and <span class=\"xn-location\">Europe<\/span>. Built on the proven Vault Platform, Veeva Basics applications allow customers to scale their technology infrastructure as they grow. For more on Veeva Basics, visit\u00a0<a href=\"https:\/\/vaultbasics.veeva.com\/\" target=\"_blank\" rel=\"nofollow\">veeva.com\/VeevaBasics<\/a>.<\/p>\n<p>\n        <b>What biotechs are saying about Veeva Basics:<br \/><\/b>&#8220;I believe Veeva Basics is a game changer, giving smaller biotech companies access to the same modern and connected applications that are typically only available to larger organizations,&#8221; said <span class=\"xn-person\">Ian Hodgson<\/span>, Ph.D., chief operating officer at Corbus Pharmaceuticals, Inc. &#8220;As our company continues to grow, I am confident that Veeva&#8217;s platform can scale with us and help ensure we remain up to date as regulatory requirements evolve.&#8221;<\/p>\n<p>&#8220;As we expand our studies to a larger scale, Veeva eTMF Basics gives us more control of our data and process to ensure inspection readiness,&#8221; said <span class=\"xn-person\">Joe Thornton<\/span>, associate director, clinical operations at Scancell. &#8220;Having an industry-leading solution with pre-configured best practices\u00a0as our foundation for trials will help drive speed and innovation as we continue to develop novel immunotherapies.&#8221;<\/p>\n<p>&#8220;The global support and training provided with Veeva Basics helps us gain maximum value from Veeva&#8217;s industry solution,&#8221; said <span class=\"xn-person\">Rebecca Deng<\/span>, Ph.D., associate director, regulatory affairs and QA systems at Terns Pharmaceuticals. &#8220;With a simple path to go live and validation, Veeva Basics has delivered significant time and resource savings.&#8221;<\/p>\n<p>\n        <b>About Veeva Systems<br \/><\/b>Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world&#8217;s largest biopharmaceutical companies to emerging biotechs. As a <a href=\"https:\/\/www.veeva.com\/pbc\/\" target=\"_blank\" rel=\"nofollow\">Public Benefit Corporation<\/a>, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit <a href=\"http:\/\/veeva.com\/\" target=\"_blank\" rel=\"nofollow\">veeva.com<\/a>.<\/p>\n<p>\n        <b>Veeva Forward-looking Statements<br \/><\/b>This release contains forward-looking statements regarding Veeva&#8217;s products and services and the expected results or benefits from use of our products and services, including certain of our new solutions and applications that are still under development or not generally available. These statements are based on our current expectations. Actual results, availability, and any future events relating to these products and services could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-K for the fiscal year ended <span class=\"xn-chron\">January 31, 2025<\/span>, which you can find <a href=\"https:\/\/www.sec.gov\/ix?doc=\/Archives\/edgar\/data\/0001393052\/000139305225000022\/veev-20250131.htm#i7e129a0ad48d459ea13c21cd7e2de073_124\" target=\"_blank\" rel=\"nofollow\">here<\/a>\u00a0(a summary of risks which may impact our business can be found on pages 9 and 10), and in our subsequent SEC filings, which you can access at <a href=\"https:\/\/www.sec.gov\/\" target=\"_blank\" rel=\"nofollow\">sec.gov<\/a>.<\/p>\n<p>\n        <b>Contact:<\/b>\n      <\/p>\n<p>\n        <span class=\"xn-person\">Deivis Mercado<\/span><br \/>\n        <br \/>Veeva Systems<br \/>925-226-8821<br \/><a href=\"mailto:deivis.mercado@veeva.com\" target=\"_blank\" rel=\"nofollow\">deivis.mercado@veeva.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF91715&amp;sd=2025-05-20\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality-302460294.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality-302460294.html<\/a><\/p>\n<p>SOURCE  Veeva Systems<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF91715&amp;Transmission_Id=202505200703PR_NEWS_USPR_____SF91715&amp;DateId=20250520\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies PLEASANTON, Calif. , May 20, 2025 \/PRNewswire\/ &#8212; Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and gaining a system that can scale as they expand their business. The rapid adoption of Veeva Basics signals a shift from disparate entry-level tools toward complete, best-of-breed solutions that can support biotechs today and as they grow. Designed specifically for fast-growing companies, Veeva Basics provides pre-configured and pre-validated solutions. This enables fast deployment and adoption regardless &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-852664","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies PLEASANTON, Calif. , May 20, 2025 \/PRNewswire\/ &#8212; Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and gaining a system that can scale as they expand their business. The rapid adoption of Veeva Basics signals a shift from disparate entry-level tools toward complete, best-of-breed solutions that can support biotechs today and as they grow. Designed specifically for fast-growing companies, Veeva Basics provides pre-configured and pre-validated solutions. This enables fast deployment and adoption regardless &hellip; Continue reading &quot;More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-20T11:08:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality\",\"datePublished\":\"2025-05-20T11:08:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/\"},\"wordCount\":723,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1488285\\\/Veeva_Systems_Logo_v2.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/\",\"name\":\"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1488285\\\/Veeva_Systems_Logo_v2.jpg\",\"datePublished\":\"2025-05-20T11:08:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1488285\\\/Veeva_Systems_Logo_v2.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1488285\\\/Veeva_Systems_Logo_v2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/","og_locale":"en_US","og_type":"article","og_title":"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality - Market Newsdesk","og_description":"PR Newswire Delivers pre-configured, pre-validated software that can scale with the needs of fast-growing companies PLEASANTON, Calif. , May 20, 2025 \/PRNewswire\/ &#8212; Veeva Systems (NYSE: VEEV) today announced that Veeva Basics is being used by more than 75 biotechs to gain efficiency and reduce costs across clinical, regulatory, and quality. With standardized applications, biotechs are going live with industry-leading software in weeks and gaining a system that can scale as they expand their business. The rapid adoption of Veeva Basics signals a shift from disparate entry-level tools toward complete, best-of-breed solutions that can support biotechs today and as they grow. Designed specifically for fast-growing companies, Veeva Basics provides pre-configured and pre-validated solutions. This enables fast deployment and adoption regardless &hellip; Continue reading \"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-20T11:08:32+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality","datePublished":"2025-05-20T11:08:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/"},"wordCount":723,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/","name":"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.jpg","datePublished":"2025-05-20T11:08:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1488285\/Veeva_Systems_Logo_v2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/more-than-75-emerging-biotechs-use-veeva-basics-across-clinical-regulatory-and-quality\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"More Than 75 Emerging Biotechs Use Veeva Basics Across Clinical, Regulatory, and Quality"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=852664"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852664\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=852664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=852664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=852664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}